SK pharmteco Focusing On BAU Amid BIO 'Buzz', BIOSECURE

Planned Act Already Prompting CDMO Shifts?

 
• By Jung Won Shin
  
Joerg Ahlgrimm, CEO of SK pharmteco
SK pharmteco CEO Joerg Ahlgrimm (left) at BIO 2024 • Source: SK pharmteco
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia